The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2024 | The role of asparaginase in the treatment of ALL
Nicolas Boissel, MD, PhD, Saint-Louis Hospital, Paris, France, discusses the role of asparaginase in the treatment of acute lymphoblastic leukemia (ALL), highlighting that the agent is an integral part of the chemotherapy backbone for adolescent and adult patients with the disease. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
